[1]
„Improving the Drug Bioavailability Property of Myricetin through a Structural Monosubstitution Modification Approach: an In-Silico Pharmacokinetics Study", AJBR, roč. 22, č. 3, s. 347–352, pro. 2019, Viděno: 21. květen 2026. [Online]. Dostupné z: https://www.ojshostng.com/index.php/ajbr/article/view/1335